MedTrace Logo

Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures

NCT02140528 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-04-27

No results posted yet for this study

Summary

This study is a case-control prospective, clinal trial to assess the safety and efficacy of the allogeneic adipose derived mesenchymal stem cell transplantation on the healing of recent tibial fracture in 40 patients.

Conditions

  • Tibial Fracture

Interventions

BIOLOGICAL

Mesenchymal stem cell injection

Injection of adipose derived mesenchymal stem cell in the site of tibia fracture .

BIOLOGICAL

Placebo

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Hamid Gourabi, PhD · Head of Royan Institute

  • Nasser Aghdami, MD,PhD · Head of regenerative medicine department &cell therapy center of Royan Institute

  • Mohsen Emaddedin, MD · Department or regenerative medicine of Royan Institute.

  • Aziz Ahmadi, MD · Scientific board of Iranian Orthopedic Association

  • Maedeh Ghorbani, MD · Department of Regenerative Medicine

  • Afshin Farhadi, MD · Scientific board of Iranian Orthopedic Association

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-03-31
Completion
2016-04-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02140528 on ClinicalTrials.gov